BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21091098)

  • 21. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hepatitis C virus infection on health-related quality of life in prisoners.
    Thein HH; Butler T; Krahn M; Rawlinson W; Levy MH; Kaldor JM; Dore GJ
    J Urban Health; 2006 Mar; 83(2):275-88. PubMed ID: 16736376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand.
    Sheerin IG; Green FT; Sellman JD
    Drug Alcohol Rev; 2003 Jun; 22(2):159-67. PubMed ID: 12850902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
    Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
    Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of hospital care of liver disease associated with hepatitis C in the United States.
    Kim WR; Gross JB; Poterucha JJ; Locke GR; Dickson ER
    Hepatology; 2001 Jan; 33(1):201-6. PubMed ID: 11124837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].
    Niederau C; Bemba G; Kautz A
    Z Gastroenterol; 2006 Apr; 44(4):305-17. PubMed ID: 16625459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis.
    Kobelt G; Berg J; Lindgren P; Jönsson B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S5-13. PubMed ID: 17310344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
    Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
    Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental treatment expenditure of diabetes in the United States.
    Balu S
    Manag Care Interface; 2007 Apr; 20(4):20-7. PubMed ID: 17474327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients.
    Vekeman F; Yameogo ND; Lefebvre P; Bailey RA; McKenzie RS; Piech CT
    J Med Econ; 2010; 13(4):673-80. PubMed ID: 21050062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
    Noyes K; Liu H; Li Y; Holloway R; Dick AW
    Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: implications for service directions.
    Williams P; Narciso L; Browne G; Roberts J; Weir R; Gafni A
    AIDS Educ Prev; 2005 Apr; 17(2):119-30. PubMed ID: 15899750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan.
    Liu GG; DiBonaventura Md; Yuan Y; Wagner JS; L'Italien GJ; Langley P; Kamae I
    Value Health; 2012; 15(1 Suppl):S65-71. PubMed ID: 22265070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.
    Fleming CA; Christiansen D; Nunes D; Heeren T; Thornton D; Horsburgh CR; Koziel MJ; Graham C; Craven DE
    Clin Infect Dis; 2004 Feb; 38(4):572-8. PubMed ID: 14765352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medico-economic assessment of the therapeutic management of patients with hepatitis C].
    Loubière S; Rotily M; Moatti JP
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1047-51. PubMed ID: 11139674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of obesity on health service utilization and costs in childhood.
    Trasande L; Chatterjee S
    Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of psychiatric diagnoses, health service use, and expenditures in children with obesity-related health conditions.
    Janicke DM; Harman JS; Kelleher KJ; Zhang J
    J Pediatr Psychol; 2009; 34(1):79-88. PubMed ID: 18522995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.